Gina Ringgold - Shanrong Biotechnology CFO, Secretary, Director
SRBT Stock | USD 0.32 0.33 50.77% |
Director
Mrs. Gina A. Ringgold serves as Chief Financial Officer, Secretary, Director of Defense Solutions Holding, Inc., since July 2010. She became a member of the Board of Directors upon completion of the Merger. Since the founding of Defense Solutions, Inc. in 2001, Mrs. Ringgold has performed various duties ranging from bookkeeping to overall company financial management. Mrs. Ringgold is a graduate of West Chester University and has more than 35 years teaching experience. since 2010.
Age | 68 |
Tenure | 15 years |
Phone | 310-359-6895 |
Similar Executives
Showing other executives | DIRECTOR Age | ||
David Bronczek | Tyson Foods | 66 | |
Jonathan Mariner | Tyson Foods | 66 | |
Alejandro Davila | BBB Foods | 47 | |
Diego Apalategui | BBB Foods | 48 | |
Barbara Tyson | Tyson Foods | 71 | |
Mike Beebe | Tyson Foods | 74 | |
Gaurdie Banister | Tyson Foods | 62 | |
Robert Thurber | Tyson Foods | 72 | |
Les Baledge | Tyson Foods | 61 | |
Jeffrey Schomburger | Tyson Foods | 58 | |
Pablo Grattarola | BBB Foods | 52 | |
Cheryl Miller | Tyson Foods | 48 | |
Mikel Durham | Tyson Foods | 57 | |
Javier Suarez | BBB Foods | 48 | |
Luis Bermdez | BBB Foods | 54 |
Shanrong Biotechnology Leadership Team
Elected by the shareholders, the Shanrong Biotechnology's board of directors comprises two types of representatives: Shanrong Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanrong. The board's role is to monitor Shanrong Biotechnology's management team and ensure that shareholders' interests are well served. Shanrong Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanrong Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gina Ringgold, CFO, Secretary, Director | ||
Colonel Ringgold, Director, CEO | ||
Paul Benson, Llc Energy | ||
Dilesh Patel, Llc Oil |
Shanrong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shanrong Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 914.35 K | |||
Shares Outstanding | 380.98 K | |||
Price To Sales | 0.52 X | |||
Net Income | (31.75 K) | |||
Cash And Equivalents | 30.87 K | |||
Cash Per Share | 0.04 X | |||
Total Debt | 2.22 M | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (31.75 K) | |||
Earnings Per Share | (0) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Shanrong Pink Sheet Analysis
When running Shanrong Biotechnology's price analysis, check to measure Shanrong Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanrong Biotechnology is operating at the current time. Most of Shanrong Biotechnology's value examination focuses on studying past and present price action to predict the probability of Shanrong Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanrong Biotechnology's price. Additionally, you may evaluate how the addition of Shanrong Biotechnology to your portfolios can decrease your overall portfolio volatility.